Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C34H32N4O4.2Cl.Sn |
| Molecular Weight | 750.258 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Cl-].[Cl-].[Sn+4].CC1=C2NC(C=C3N=C(C=C4NC(=CC5=NC(=C2)C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC([O-])=O)=C1CCC([O-])=O
InChI
InChIKey=KXYSGXXTXAHPIX-UHEVNVKKSA-J
InChI=1S/C34H34N4O4.2ClH.Sn/c1-7-21-17(3)25-13-26-19(5)23(9-11-33(39)40)31(37-26)16-32-24(10-12-34(41)42)20(6)28(38-32)15-30-22(8-2)18(4)27(36-30)14-29(21)35-25;;;/h7-8,13-16,35,38H,1-2,9-12H2,3-6H3,(H,39,40)(H,41,42);2*1H;/q;;;+4/p-4/b25-13-,26-13-,27-14-,28-15-,29-14-,30-15-,31-16-,32-16-;;;
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C34H32N4O4 |
| Molecular Weight | 560.6423 |
| Charge | -2 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | Sn |
| Molecular Weight | 118.71 |
| Charge | 4 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:14:07 GMT 2025
by
admin
on
Mon Mar 31 22:14:07 GMT 2025
|
| Record UNII |
DIO3JT9G2P
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C203180
Created by
admin on Mon Mar 31 22:14:07 GMT 2025 , Edited by admin on Mon Mar 31 22:14:07 GMT 2025
|
PRIMARY | |||
|
300000023097
Created by
admin on Mon Mar 31 22:14:07 GMT 2025 , Edited by admin on Mon Mar 31 22:14:07 GMT 2025
|
PRIMARY | |||
|
KL-193
Created by
admin on Mon Mar 31 22:14:07 GMT 2025 , Edited by admin on Mon Mar 31 22:14:07 GMT 2025
|
PRIMARY | |||
|
DIO3JT9G2P
Created by
admin on Mon Mar 31 22:14:07 GMT 2025 , Edited by admin on Mon Mar 31 22:14:07 GMT 2025
|
PRIMARY | |||
|
267099
Created by
admin on Mon Mar 31 22:14:07 GMT 2025 , Edited by admin on Mon Mar 31 22:14:07 GMT 2025
|
PRIMARY | |||
|
14325-05-4
Created by
admin on Mon Mar 31 22:14:07 GMT 2025 , Edited by admin on Mon Mar 31 22:14:07 GMT 2025
|
PRIMARY | |||
|
13000
Created by
admin on Mon Mar 31 22:14:07 GMT 2025 , Edited by admin on Mon Mar 31 22:14:07 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
In addition to its cytoprotective activity RBT-9 has been shown to inhibit viral infection of several enveloped arboviruses by inhibiting the synthesis of nonstructural protein 1 (NSP1)which plays an early role in viral infection and is critical for blocking the innate immune
response that protects the body from viral infection. Importantly, these effects were observed without a loss of host cell viability.
|
